Question

In: Accounting

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

1

Dec. 31, 20Y3

Dec. 31, 20Y2

2

Assets

3

Cash

$625,650.00

$586,340.00

4

Accounts receivable (net)

228,170.00

208,030.00

5

Inventories

641,480.00

617,130.00

6

Investments

0.00

240,290.00

7

Land

328,170.00

0.00

8

Equipment

706,070.00

552,300.00

9

Accumulated depreciation-equipment

(165,580.00)

(147,010.00)

10

Total assets

$2,363,960.00

$2,057,080.00

11

Liabilities and Stockholders’ Equity

12

Accounts payable (merchandise creditors)

$424,300.00

$404,860.00

13

Accrued expenses payable (operating expenses)

41,850.00

52,880.00

14

Dividends payable

23,200.00

19,880.00

15

Common stock, $4 par

153,000.00

99,000.00

16

Paid-in capital: Excess of issue price over par—common stock

418,000.00

279,800.00

17

Retained earnings

1,303,610.00

1,200,660.00

18

Total liabilities and stockholders’ equity

$2,363,960.00

$2,057,080.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

A. The investments were sold for $280,680 cash.
B. Equipment and land were acquired for cash.
C. There were no disposals of equipment during the year.
D. The common stock was issued for cash.
E. There was a $199,210 credit to Retained Earnings for net income.
F. There was a $96,260 debit to Retained Earnings for cash dividends declared.

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Score: 153/173

Livers Inc.

Statement of Cash Flows

?

1

Cash flows from operating activities:

2

?

?

3

Adjustments to reconcile net income to net cash flow from operating activities:

4

?

?

5

?

?

6

Changes in current operating assets and liabilities:

7

?

?

8

?

?

9

?

?

10

?

?

11

?

12

13

Cash flows from investing activities:

14

?

?

15

?

?

16

?

?

17

?

?

18

19

Cash flows from financing activities:

20

?

21

?

?

22

?

23

?

24

Cash at the beginning of the year

?

25

Cash at the end of the year

Solutions

Expert Solution

Solution

Livers Inc

Statement of cash flows:

Livers Inc

Statement of Cash Flows (Indirect Method)

for the year ended December 31, 20Y3

Cash flows from operating activities:

Net Income

$199,210

Adjustments to reconcile net income to net cash flow from operating activities:

Depreciation expense

$18,570

gain on sale of investments

($40,390)

Changes in current operating assets and liabilities:

Increase in accounts receivable

($20,140)

Increase in inventory

($24,350)

increase in accounts payable

$19,440

decrease in accrued expenses payable

($11,030)

increase in dividends payable

$3,320

-54,580

Cash flow from operating activities

$144,630

Cash flow from investing activities:

Proceeds from sale of investment

$280,680

Purchase of land

($328,170)

Purchase of equipment

($153,770)

Cash flow from investing activities

($201,260)

Cash flow from financing activities:

Issue of common stock

$192,200

Dividends paid

($96,260)

Cash flow from financing activities

$95,940

Excess of cash

$39,310

Beginning balance

$586,340

Ending cash balance

$625,650

Note:

Cash from issue of common stock –

Increase in common stock par value = $54,000

Add: increase in paid-in capital$138,200

Cash from issue of common stock$192,200

Gain on sale of investments:

Sale proceeds$280,680

Less: Book value $240,290

Gain on sale $40,390


Related Solutions

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $262,580 $246,510 Accounts receivable (net) 95,120 88,540 Inventories 268,530 262,130 Investments 0 101,560 Land 137,730 0 Equipment 296,270 231,760 Accumulated depreciation—equipment (69,360) (62,500) Total assets $990,870 $868,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $179,350 $171,000 Accrued expenses payable (operating expenses) 17,840 22,570 Dividends payable 9,910 7,810 Common stock, $10 par 53,510 42,530 Paid-in...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,100.00 $585,190.00 4 Accounts receivable (net) 228,630.00 208,060.00 5 Inventories 641,030.00 617,620.00 6 Investments 0.00 239,830.00 7 Land 328,160.00 0.00 8 Equipment 705,110.00 553,850.00 9 Accumulated depreciation-equipment (166,840.00) (147,700.00) 10 Total assets $2,362,190.00 $2,056,850.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $423,690.00 $404,660.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,080.00 $586,430.00 4 Accounts receivable (net) 228,260.00 209,470.00 5 Inventories 641,070.00 616,400.00 6 Investments 0.00 240,170.00 7 Land 327,640.00 0.00 8 Equipment 705,000.00 552,830.00 9 Accumulated depreciation-equipment (165,670.00) (148,610.00) 10 Total assets $2,361,380.00 $2,056,690.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,090.00 $405,900.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $306,450 $282,770 Accounts receivable (net) 111,020 101,560 Inventories 313,390 300,700 Investments 0 116,490 Land 160,740 0 Equipment 345,770 265,850 Accumulated depreciation—equipment (80,950) (71,690) Total assets $1,156,420 $995,680 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $209,310 $196,150 Accrued expenses payable (operating expenses) 20,820 25,890 Dividends payable 11,560 8,960 Common stock, $10 par 62,450 48,790 Paid-in...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,680.00 $586,230.00 4 Accounts receivable (net) 228,100.00 208,850.00 5 Inventories 640,910.00 617,650.00 6 Investments 0.00 240,620.00 7 Land 328,090.00 0.00 8 Equipment 704,540.00 553,320.00 9 Accumulated depreciation-equipment (166,310.00) (147,840.00) 10 Total assets $2,361,010.00 $2,058,830.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,280.00 $404,550.00 13 Accrued expenses payable (operating expenses)...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT